Logo-apb

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308 
pISSN: 2228-5881 

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by
Adv Pharm Bull. 2024;14(3): 513-523. doi: 10.34172/apb.2024.061
PMID: 39494254        PMCID: PMC11530870

Review Article

Nanomedicine Strategies Utilizing Lipid-Based Nanoparticles for Liver Cancer Therapy: Exploring Signaling Pathways and Therapeutic Modalities

Fereshteh Asgharzadeh 1 ORCID, Maryam Moradi Binabaj 2, Sahar Fanoudi 3, William C. Cho 4, Yu-jeong Yang 5, Maryam Azarian 6, Mehdi Shafiee Ardestani 7, Nasim Nasiri 8, Marzieh Ramezani Farani 5 * ORCID, Yun Suk Huh 5 * ORCID

Cited by CrossRef: 0

1- Asgharzadeh F, Moradi Binabaj M, Fanoudi S, C. Cho W, Kang H, Elyasi Z, Farasati Far B, Pourmolaei A, Ramezani Farani M, Huh Y. Lipid-based nanomedicine for colorectal cancer: Progress and prospects. Alexandria Engineering Journal. 2025;122:385 [Crossref]
2- Han H, Kim S, Kim D. Mechanotransduction for therapeutic approaches: Cellular aging and rejuvenation. 2025;9(2) [Crossref]
3- Toropova A, Toropov A, Jr I, Raskova M, Benfenati E, Leszczynska D, Leszczynski J. Chaos, gambling, simplicity: simulation of nanoparticle delivery efficiency to organs of mice. In Silico Research in Biomedicine. 2025;1:100105 [Crossref]
4- Lin J, Cai Y, Chen Z, Ma J, Zhao K. miR-4484 suppresses hepatocellular carcinoma progression via targeting KIF2C . RNA Biology. 2025;22(1):1 [Crossref]